SCHEMBL705309

SCHEMBL705309

CCN(CC(=O)OC)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
NOX1 Q9Y5S8 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
MAPT P10636 2/20 0.49
ALDH1A1 P00352 5/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
RECQL P46063 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TSHR P16473 2/20 0.47
GLA P06280 1/20 0.47
MCL1 Q07820 1/20 0.47
CNR2 P34972 2/20 0.44
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27818171 0.98 MEN1 (0.50) MEN1KMT2ANOX1NPC1RAB9A
SCHEMBL8627738 0.91 POLB (0.46) MEN1KMT2ANOX1NPC1RAB9A
SCHEMBL4753823 0.90 NPC1 (0.50) MEN1KMT2ANOX1NPC1RAB9A
SCHEMBL3841166 0.86 TDP1 (0.44) MEN1KMT2ANOX1NPC1RAB9A
SCHEMBL8623129 0.85 SMN1; SMN2 (0.51) MEN1KMT2AALDH1A1GAASMN1; SMN2
SCHEMBL6486619 0.84 SMN1; SMN2 (0.54) MEN1KMT2ANOX1NPC1RAB9A
SCHEMBL13603950 0.83 MEN1 (0.50) MEN1KMT2ANOX1NPC1RAB9A
SCHEMBL7038319 0.83 MEN1 (0.49) MEN1KMT2ANOX1NPC1RAB9A
SCHEMBL9031711 0.83 TSHR (0.53) NPC1RAB9AALDH1A1CYP2C19NPSR1
Hydrochloric Acid SCHEMBL27837763 0.83 ALDH1A1 (0.43) MEN1KMT2ANOX1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3851166-B1 STABLE DISPERSIONS SYMRISE AG (DE) 2024-05-29 EP disclosed
US-20240001280-A1 Automatic Spray Dispenser STATION10, LLC (US) 2024-01-04 US disclosed
CN-116847825-A Perfume delivery composition 塔明克私人有限公司 2023-10-03 CN disclosed
CN-116744887-A Cosmetic care or fragrance composition in two-phase form LVMH研究公司 2023-09-12 CN disclosed
US-11661569-B2 Liquid detergent composition comprising suspended solid particles HENKEL AG & CO. KGAA (DE) 2023-05-30 US disclosed
WO-2023043449-A1 AUTOMATIC SPRAY DISPENSER STATION 10, LLC (US) 2023-03-23 WO disclosed
US-11344857-B2 Microcapsules SYMRISE AG (DE) 2022-05-31 US disclosed
US-20210380331-A1 Automatic Spray Dispenser STATION10, LLC 2021-12-09 US disclosed
EP-3851166-A1 STABLE DISPERSIONS Symrise AG (DE) 2021-07-21 EP disclosed
EP-3261724-B1 FRAGRANCE DISPERSION FOR DETERGENT COMPOSITIONS SYMRISE AG (DE) 2021-04-28 EP disclosed
US-20050238711-A1 Filled depression tablets and method for their production II HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2005-10-27 US disclosed
US-20050164225-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2005-07-28 US disclosed
WO-2005049568-A1 A PROCESS FOR INDUSTRIALLY VIABLE PREPARATION OF (S,S,S) PHENYLMETHYL-2-AZABICYCLO-[3.3.0]-OCTANE-3-CARBOXYLATE TOSYLATE BABU POTLURI RAMESH (IN) 2005-06-02 WO disclosed
US-20040005607-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2004-01-08 US disclosed
US-20030082547-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2003-05-01 US disclosed
WO-2003019145-A2 NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS APPLERA CORPORATION (US) 2003-03-06 WO disclosed
CN-1284991-A Washing and cleaning sheet containing bleaching agent HENKEL KGAA (DE) 2001-02-21 CN disclosed
CN-1284990-A Multi-phase washing and cleaning sheet with optimized phase separation HENDKEL KOMMANDITAESELLSCHAFT (DE) 2001-02-21 CN disclosed
CN-1284992-A Shaped bodies of detergent with improved properties HENKEL KGAA (DE) 2001-02-21 CN disclosed
WO-1997011949-A1 DIAZABICYCLOOCTANE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1997-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050164225-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MEN1 3909/4885KMT2A 4016/4885NOX1 2569/4885
US-20050238711-A1 Filled depression tablets and method for their production II GRIN2D, GRIN2A, BDNF MEN1 3280/4885KMT2A 204/4885NOX1 4310/4885
US-20030082547-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MEN1 3627/4885KMT2A 4176/4885NOX1 1878/4885
US-20040005607-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MEN1 3627/4885KMT2A 4176/4885NOX1 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.